Cardiac MRI in patients with COVID-19 infection

[1]  J. Udell,et al.  Cardiac MRI Assessment of Nonischemic Myocardial Inflammation: State of the Art Review and Update on Myocarditis Associated with COVID-19 Vaccination , 2021, Radiology. Cardiothoracic imaging.

[2]  N. Oyama-Manabe,et al.  Microvascular thrombi in recurrent myocardial injury after coronavirus disease 2019 infection , 2021, European Heart Journal.

[3]  A. Ramanan,et al.  COVID-19 vasculitis and novel vasculitis mimics , 2021, The Lancet Rheumatology.

[4]  Noreen T. Nazir,et al.  Cardiac MRI and Myocardial Injury in COVID-19: Diagnosis, Risk Stratification and Prognosis , 2021, Diagnostics.

[5]  R. Shah,et al.  Takotsubo Syndrome and COVID-19: Associations and Implications , 2020, Current Problems in Cardiology.

[6]  G. Francis,et al.  Update on COVID-19 Myocarditis , 2020, Medicina.

[7]  A. Chockalingam,et al.  Takotsubo Syndrome in Patients with COVID-19: a Systematic Review of Published Cases , 2020, SN Comprehensive Clinical Medicine.

[8]  S. Ozen,et al.  Kawasaki-like disease in children with COVID-19 , 2020, Rheumatology International.

[9]  J. Varley,et al.  Immunosuppression for intracranial vasculitis associated with SARS-CoV-2: therapeutic implications for COVID-19 cerebrovascular pathology , 2020, Journal of Neurology, Neurosurgery, and Psychiatry.

[10]  P. Kirchhof,et al.  Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases. , 2020, JAMA cardiology.

[11]  A. Jaffe,et al.  Cardiac Troponin for Assessment of Myocardial Injury in COVID-19 , 2020, Journal of the American College of Cardiology.

[12]  M. Chung,et al.  Incidence of Stress Cardiomyopathy During the Coronavirus Disease 2019 Pandemic , 2020, JAMA network open.

[13]  G. Ligabue,et al.  Cardiac Magnetic Resonance Characterization of Myocarditis-Like Acute Cardiac Syndrome in COVID-19 , 2020, JACC: Cardiovascular Imaging.

[14]  L. Cooper,et al.  Recognizing COVID-19–related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management , 2020, Heart Rhythm.

[15]  E. Arbustini,et al.  Myocardial localization of coronavirus in COVID‐19 cardiogenic shock , 2020, European journal of heart failure.

[16]  Lei Liu,et al.  First case of COVID-19 complicated with fulminant myocarditis: a case report and insights , 2020, Infection.

[17]  C. Basso,et al.  Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection , 2020, European heart journal.

[18]  N. Vaninov.  In the eye of the COVID-19 cytokine storm , 2020, Nature Reviews Immunology.

[19]  Jiyan Chen,et al.  CSC Expert Consensus on Principles of Clinical Management of Patients with Severe Emergent Cardiovascular Diseases during the COVID-19 Epidemic. , 2020, Circulation.

[20]  Ke Ma,et al.  Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study , 2020, BMJ.

[21]  Ying Wang,et al.  COVID-19 infection: the perspectives on immune responses , 2020, Cell Death & Differentiation.

[22]  Allan Schwartz,et al.  COVID-19 and Cardiovascular Disease , 2020, Circulation.

[23]  Sharukh Lokhandwala,et al.  Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State. , 2020, JAMA.

[24]  Giuseppe Biondi-Zoccai,et al.  Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic , 2020, Journal of the American College of Cardiology.

[25]  Simon Redwood,et al.  Coronaviruses and the cardiovascular system: acute and long-term implications , 2020, European heart journal.

[26]  Jing Yuan,et al.  First Case of COVID-19 Infection with Fulminant Myocarditis Complication: Case Report and Insights , 2020 .

[27]  Xiang Xie,et al.  COVID-19 and the cardiovascular system , 2020, Nature Reviews Cardiology.

[28]  Chuan Qin,et al.  Dysregulation of immune response in patients with COVID-19 in Wuhan, China , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[29]  L. Cooper,et al.  Recognition and Initial Management of Fulminant Myocarditis , 2020, Circulation.

[30]  Matthias Gutberlet,et al.  Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation: Expert Recommendations. , 2018, Journal of the American College of Cardiology.

[31]  Shinji Makino,et al.  Inhibition of Stress Granule Formation by Middle East Respiratory Syndrome Coronavirus 4a Accessory Protein Facilitates Viral Translation, Leading to Efficient Virus Replication , 2018, Journal of Virology.

[32]  Daniel Messroghli,et al.  State of the Art: Clinical Applications of Cardiac T1 Mapping. , 2016, Radiology.

[33]  R. Sato,et al.  A review of sepsis-induced cardiomyopathy , 2015, Journal of Intensive Care.

[34]  T. Masuyama,et al.  Takotsubo cardiomyopathy: Pathophysiology, diagnosis and treatment. , 2014, World journal of cardiology.

[35]  A. Lyon,et al.  Pathophysiology of Takotsubo Syndrome , 2014 .

[36]  Tiina Heliö,et al.  Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2013, European heart journal.

[37]  Matthias Gutberlet,et al.  Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper , 2009 .

[38]  B. McManus,et al.  Molecular biology and pathogenesis of viral myocarditis. , 2008, Annual review of pathology.

[39]  David M Higgins,et al.  Modified Look‐Locker inversion recovery (MOLLI) for high‐resolution T1 mapping of the heart , 2004, Magnetic resonance in medicine.

[40]  C. Roongsritong,et al.  Common causes of troponin elevations in the absence of acute myocardial infarction: incidence and clinical significance. , 2004, Chest.